Evaluating Changes in Systemic Anticancer Therapy Use Between 2015 and 2019
Drug Topics
NOVEMBER 11, 2022
While the use of chemotherapy at end of life is decreasing, the use of immunotherapy is increasing.
2015 Related Topics 
OIG audit: Aetna may have raked in $25.5M in MA overpayments in 2015, 2016
Fierce Healthcare
OCTOBER 6, 2023
million in overpayments from Medicare Advantage in 2015 and 2016. | million in overpayments from Medicare Advantage in 2015 and 2016. A new federal audit estimates that Aetna may have received at least $25.5 A new federal audit estimates that Aetna may have received at least $25.5
95 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
U.N.: Progress on reducing global maternal mortality has stalled since 2015
STAT
FEBRUARY 22, 2023
The progress the world has made in reducing maternal mortality has stalled in recent years, with some regions — including Europe and Northern America — backsliding since 2015, according to a new report from United Nations agencies.
98 
McKesson Is Ready to Help Customers Navigate DSCSA
Drug Topics
JUNE 24, 2023
The company has been working since 2015 to implement the track and trace elements required by the Drug Supply Chain Security Act.
247 
GARDASIL 9 Shows Positive Results in Phase 3 Study Against HPV-Related Cancers
Drug Topics
SEPTEMBER 5, 2023
According to the Centers for Disease Control and Prevention, tens of thousands of HPV-related cancer diagnoses were given per year from 2015 to 2019.
247 
Chronic Kidney Disease Rates in People with Diabetes Considered "Troubling"
Drug Topics
OCTOBER 17, 2022
An analysis of data from more than 640,000 people with diabetes recorded between 2015-2020 is providing new insight into what study investigators are calling "troubling" trends in the incidence of CKD in the face a growing diabetes epidemic.
247 
Texas measles outbreak marks first fatality as more cases reported
STAT
FEBRUARY 26, 2025
A child in Texas has died from measles, officials said Wednesday , the first known death in the current large outbreak in West Texas and the first death from measles in the country since 2015. Read the rest…
Vaccines 145
145 Vaccines 145
145 
Biosimilars: Are They Delivering the Cost Savings Promised?
Pharmacy Times
FEBRUARY 15, 2024
Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
FDA 152
152 FDA 152
152 
With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy
STAT
JUNE 13, 2024
Early in her pregnancy in 2015, Nicole Hashemi wanted to know how much caffeine was safe for her to consume. “I was actually advised not to drink a lot of caffeine,” Hashemi, an associate professor of mechanical engineering at Iowa State University, told STAT.
144 
3rd time's the charm: AbbVie scores FDA nod for continuous Parkinson's disease therapy Vyalev
Fierce Pharma
OCTOBER 17, 2024
AbbVie made history in 2015 with its Parkinson’s disease infusion pump therapy Duopa, kicking off a trend of delivery system innovation in the space as drugmakers sought to avoid the common pitfall | The 24-hour Parkinson's disease therapy crossed the FDA finish line after an initial manufacturing-related rejection last year and another snub in (..)
FDA 125
125 FDA 125
125 
Precision medicine company Tempus AI files to go public
Fierce Healthcare
MAY 21, 2024
Founded in 2015, Tempus says it’s built the world’s largest library of clinical and molecular data along with an operating system to make those data accessible and useful for providers to inform patient care. Three years after talks of an IPO surfaced, health tech company Tempus AI lit the fuse and is looking to go public this year.
Patient Care 124
124 Patient Care 124
124 
Mallinckrodt sells Therakos unit on at a discount
pharmaphorum
AUGUST 6, 2024
Mallinckrodt agrees to sell Therakos to private equity firm CVC $925m, well below the $1.33bn it paid for the business in 2015
105 
Zuckerberg and Chan announce a New York biohub to build disease-fighting cellular machines
STAT
OCTOBER 18, 2023
The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the couple founded in 2015 to help cure, prevent, or manage all disease by 2100. Read the rest…
145 
STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion
STAT
JULY 6, 2023
Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2022. Snapshot of our findings In 2015, women were underrepresented on staff and in management. The percentage of the entire staff who are people of color has doubled since 2015, growing from 15% to 31%.
106 
Opinion: When life mirrors research: What a fall on the ice taught me about being Black and in pain
STAT
AUGUST 7, 2024
dissertation one day in 2015, I slipped and fell on Iowa’s formidable winter ice. As I hurried to an important meeting about my Ph.D. I quickly jumped up to prevent anyone from seeing me on the ground and got into my car. The immediate, excruciating pain told me that something really bad had happened.
126 
STAT+: CVS and its PBM agree to pay $45 million to Illinois for failing to pass drug rebates
STAT
JULY 23, 2024
This arrangement was noted in a contract that began in 2015 with the Illinois Department of Central Management Services. Illinois Attorney General Kwame Raoul began investigating CVS Caremark over concerns that rebates were not being passed back to the state, according to a June 24, 2024, settlement agreement between the state and the PBM.
Documentation 145
145 Documentation 145
145 
STAT+: Nine in 10 health care companies with financial stress are owned by private equity
STAT
DECEMBER 14, 2022
That’s compared with just 4% at the end of 2015. Among the 193 North American health care companies Moody’s rates, the agency had placed almost 18% at or below its rating that indicates credit stress, B3 negative, as of Nov. Continue to STAT+ to read the full story…
Hospitals 145
145 Hospitals 145
145 
STAT’s 2024 Diversity and Inclusion Report
STAT
OCTOBER 30, 2024
Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics. The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Read the rest…
106 
STAT+: New NIH head says government has fallen behind pharma on clinical trials
STAT
NOVEMBER 14, 2023
” A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”
144 
Todd Vasos returns as CEO of Dollar General
Drug Store News
OCTOBER 13, 2023
Vasos, who previously served as Dollar General’s CEO from June 2015 to November 2022, is returning as CEO, succeeding Jeff Owen, whose separation from the company and resignation from its board is effective today.
106 
STAT+: The effort to reform physician pay is set to pit primary care docs against highly paid specialists
STAT
JULY 15, 2024
This year, Congress began considering changes to the Medicare physician pay system for the first time since creating the current version in 2015. Committees in the House and Senate have held hearings on the matter, including the powerful Senate Finance Committee, which recently published a 30-page paper on potential changes.
126 
STAT+: A Q&A with the CEO of CRISPR Therapeutics on a historic approval and the road ahead
STAT
DECEMBER 8, 2023
The former McKinsey partner joined CRISPR Therapeutics in 2015 as its chief business officer. With the approval of Casgevy , the world’s first gene-edited therapy and a potential cure for sickle cell disease, CRISPR Therapeutics won the race. Samarth “Sam” Kulkarni has been there from almost the beginning.
127 
STAT+: Value-based payment is getting renewed attention. What it means isn’t getting any clearer
STAT
MAY 30, 2024
Lawmakers are considering changes to the way Medicare pays doctors for the first time since Congress passed a law in 2015 that leaned heavily on value-based payment. A key House committee took up the matter last fall.
Hospitals 126
126 
STAT+: 12 people changing the course of the Chinese biopharma industry
STAT
OCTOBER 7, 2024
Since 2015, the country’s National Medical Products Administration has issued one milestone regulation after another, greatly accelerating the process of reviewing new drugs. The growth of China’s industry can be attributed to a number of factors, including beneficial state policies and fresh injections of funding.
Vaccines 120
120 Vaccines 120
120 
On the road to eliminate rabies, Gavi announces plan to improve human vaccination
STAT
JUNE 18, 2024
Around the world, the viral infection kills about 70,000 people a year — and since as early as 2015, groups including Gavi, the Vaccine Alliance, have had plans to shore up vaccine efforts to reduce the number. Rabies has been in global health’s crosshairs for years.
Vaccines 117
117 Vaccines 117
117 
Opinion: In drug development, diversity must be extended to preclinical research
STAT
AUGUST 22, 2024
In 2015, the FDA began reporting on the representation of individuals in clinical trials, with the hope that raising awareness would drive meaningful change. Lack of diversity occurs at all levels of the pharmaceutical ecosystem, from the makeup of C-suite and research staffs to participation in clinical trials.
FDA 117
117 FDA 117
117 
Pfizer settles gender pay discrimination allegations at NYC headquarters
Fierce Pharma
OCTOBER 18, 2023
The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. |
103 
Women in Science: Dr Laura Trotta – ‘I joined CluePoints because of the research but also the mindset’
Outsourcing Pharma
APRIL 3, 2024
Dr Laura Trotta joined CluePoints in 2015 and moved into her current role as vice president of research in January 2022, where she leads a team of research scientists responsible for developing new statistical and machine learning algorithms to assess the quality of clinical trial data.
89 
STAT+: Illumina board agrees to spin off Grail, as divestment plans proceed
STAT
JUNE 3, 2024
It’s the second time Illumina has spun off Grail, which initially began as a unit within the DNA sequencing giant in 2015. Illumina will retain a 14.5% stake in the company, which will trade under the ticker $GRAL. Continue to STAT+ to read the full story…
109 
STAT+: Grail, aiming to launch a blood test for cancer, faces host of challenges as it debuts on Nasdaq
STAT
JUNE 24, 2024
Grail was spun out by the DNA sequencing giant Illumina in 2015. On Tuesday, shares of Grail, the liquid biopsy company that hopes that its test, Galleri, will be widely used to screen for cancer, will become a publicly traded stock (with the ticker GRAL) that any investor can buy or sell on the Nasdaq.
118 
Opinion: Moving from crisis response to crisis prevention in U.S. mental health systems
STAT
FEBRUARY 8, 2024
People with unmet mental health needs are 16 times more likely to be killed by police, and a quarter of all those killed by police since 2015 were perceived to be suffering from a mental health crisis. Meanwhile, there is now an historic amount of money flowing through the mental health industry, and the U.S.
145 
STAT+: Zuckerberg and Chan on track to put $50 billion toward science: ‘That’s the trajectory we’re on’
STAT
OCTOBER 19, 2023
In 2015, when the self-described science nerds pledged 99 percent of their Facebook fortune to philanthropic causes over their lifetimes, they did not specify how they might spread their wealth.
Compounding 130
130 Compounding 130
130 
New IQVIA research reveals growing trend as pharma embraces combined PV solutions
Outsourcing Pharma
APRIL 17, 2024
Archana Hegde joined IQVIA in 2015 and has been in various leadership roles implementing technology solutions to support critical business processes.
76 
STAT+: UnitedHealth executive to head health insurance group AHIP
STAT
DECEMBER 11, 2023
Notably, UnitedHealth group is not a member of AHIP after the company left in 2015. AHIP has selected Mike Tuffin, who’s currently UnitedHealth’s senior vice president for external affairs and head of U.S. Continue to STAT+ to read the full story…
Insurance 103
103 Insurance 103
103 
STAT+: Unicorn down: Following layoffs, Biofourmis CEO quietly departs
STAT
AUGUST 30, 2023
Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions. The Boston-based company was valued at $1.3
Hospitals 122
122 Hospitals 122
122 
STAT+: New insights into how tumor cells hijack brain plasticity to drive cancer
STAT
NOVEMBER 1, 2023
First reported in Cell in 2015, research led by Stanford neuro-oncologist Michelle Monje showed that active nerve cells could promote the growth of high-grade gliomas, a form of brain cancer with a poor prognosis.
118 
Exercise is good for health — but why? A study in rats offers insight
STAT
MAY 1, 2024
To answer those questions, researchers launched a large, 10-year study in 2015 to understand the biological impact of physical activity in both rats and humans. Yet science doesn’t have a clear understanding of what makes moving so good for us, including what molecular mechanisms are activated by exercise.
93 
STAT+: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
STAT
OCTOBER 30, 2023
When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb.
Chemotherapy 129
129 Chemotherapy 129
129 
Peculiar Articles: 10 Potential Conversation Starters From The Medical Literature
IDStewardship
DECEMBER 15, 2024
What happens when a human swallows a lego head? This is a fun article, including the SHAT score (stool hardness and transit) and the FARTscore (found and retrieved time). The science behind man flu. Is “man flu” an actual thing? In this articleKyle Sue explores whether men are wimps or just immunologically inferior. A Viper Bite.
130 
Alzheimer’s therapeutics market to reach $6.8 billion by 2032
European Pharmaceutical Review
DECEMBER 16, 2022
In 2015, Alzheimer’s Therapeutics International found there was an estimated 46.8 According to Alzheimer’s Therapeutics International in 2015, 58 percent of people with dementia live in developing countries, but by 2050 this will rise to 68 percent. percent, and driven largely by collaboration of existing players, reach $6.8
Compounding 98
98 
STAT+: Researchers devise new strategies to overcome a key CRISPR flaw
STAT
MARCH 22, 2023
Since those first 2015 papers, dozens more have been published and multiple startups have launched, spurred by the hope that CRISPR could outperform the gene therapy approaches now nearing approval.
98 
STAT+: Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma
STAT
MARCH 30, 2023
company that spun out of the lab of Harvard University biologist Greg Verdine in 2015. Mammen, previously a candidate for the top job at Biogen , will take over as chairman, president, and CEO of FogPharma, a Cambridge, Mass.,
102 
STAT+: Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
STAT
SEPTEMBER 15, 2022
This purportedly contributed to nearly 6,000 deaths from the disease between 2015 and 2017, according to documents filed with the Administrative Council for Economic Defense. Continue to STAT+ to read the full story…
STAT+: ‘Skinny labels’ on generic medicines saved Medicare $15 billion over a recent six-year period
STAT
APRIL 30, 2024
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis.
Labelling 105
105 
Let's personalize your content